background image
32 Robert WoodJohnson
I
MEDICINE
A
n affiliation agreement
signed by Rutgers Bio-
medical and Health
Sciences (RBHS) and Saint
Peter's Healthcare System will
enhance medical education,
the delivery of health care,
and research opportunities
within the state of New
Jersey. On July 1, 2014, Saint
Peter's became a Major Clin-
ical Affiliate with Rutgers
Robert Wood Johnson Med-
ical School, Rutgers Cancer
Institute of New Jersey, and
Rutgers New Jersey Medical
School, all units
within RBHS.
"We look forward
to working with
Saint Peter's Health-
care System in a new
and exciting way," says
Brian L. Strom, MD, MPH
,
chancellor of RBHS. "The
affiliate relationship with
Saint Peter's will provide
enhanced
clinical
care,
expanded educational oppor-
tunities, and greater access to
clinical trials with the over-
all goal of continually im-
proving the health of the
community."
The affiliation agreement
will include collaboration
on fellowship programs, res-
idency rotations, and med-
ical school clerkships--from
primary care to specialty and
subspecialty programs and
clinical trials.
Continu i n g
medical edu-
cation will be
provided by
Rutgers.
"Saint Peter's initiated
this affiliation because we
believe that by working
together and building strong
partnerships, Rutgers and
Saint Peter's will best serve
the interests of our commu-
nities and the state of New
Jersey," says
Ronald C. Rak,
JD
, president and CEO of
Saint Peter's Healthcare
System. "The creation of
Rutgers Biomedical and
Health Sciences has launch-
ed a new era for the advance-
ment of medicine in New
Jersey, and Saint Peter's is
thrilled to be a key part of
that endeavor."
N
EWS
Brian L. Strom, MD, MPH
Rutgers and Saint Peter's Healthcare System
Sign Affiliation Agreement
T
he National Institutes of
Health awarded a $2M
BEST
(Broadening
Experiences
in Scientific
Training)
Award to
Rutgers
University,
one of only
seven uni-
versities
selected for
the award.
The grant
will support
expanded
training for doctoral and post-
doctoral biomedical research-
ers, exposing them to career
opportunities outside acade-
mia.
James H. Millonig, PhD
,
senior associate dean, Rutgers
Graduate School of Biomed-
ical Sciences, and associate
professor of neuroscience
and cell biology, is one of
two principal investigators
(PI) on the project. His co-PI
is
Martin Yarmush, MD, PhD
,
Paul and Mary Monroe
Chair and Distinguished Pro-
fessor of Biomedical Engine-
ering and director, Center
for Innovative Ventures of
Emerging Technologies
(CIVET) at Rutgers.
$2 Million Grant Will Broaden
Career Choices for Top Biomedical Students
CHINJ Celebrates
10th Anniversary:
James H. Millonig, PhD
Martin Yarmush,
MD, PhD
J
O
H
N

E
M
E
R
S
O
N
T
he Child Health Institute of New Jersey (CHINJ)
celebrated its 10th anniversary at a reception
on December 2, 2014.
Arnold B. Rabson, MD
,
professor of pediatrics, pharmacology, and
pathology and laboratory medicine, and director,
CHINJ, expressed his appreciation for the tremen-
dous contributions of Johnson & Johnson and the
Robert Wood Johnson Foundation for providing
critical funds for the construction of this building,
the initial endowment, and the start-up support to
hire the outstanding faculty who enrich not only
our pediatric research community, but also the
entire academic environment of
Rutgers
and the
Robert Wood Johnson Medical School
."
"
S
T
E
V
E

H
O
C
K
S
T
E
I
N
B y K a t e O ' N e i l l
J
O
H
N

E
M
E
R
S
O
N